FDA Bans Imports From Apotex's India Drug Plant
The U.S. Food and Drug Administration on Wednesday banned imports from Canadian pharmaceutical company Apotex Inc.'s Indian drug manufacturing facility, the latest in a string of quality control crackdowns by the...To view the full article, register now.
Already a subscriber? Click here to view full article